N-Nitroso Tadalafil
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Tadalafil is used to treat men who have erectile dysfunction (also called sexual impotence). Tadalafil belongs to a group of medicines called phosphodiesterase 5 (PDE5) inhibitors. These medicines prevent an enzyme called phosphodiesterase type-5 from working too quickly.Tadalafil Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Tadalafil or Tadalafil Nitroso Impurity 1 CAS NO:NA also known as N-Nitroso Tadalafil Impurity Chemically represented as (6R,12aR)-6-(Benzo[d][1,3]dioxol-5-yl)-2-methyl-7-nitroso-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione . Synchemia is the leading manufacturing and exporter of Tadalafil Nitroso Impurity 1 . We supply Tadalafil Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014451 |
| CAS No | NA |
| Mol.F. | C29H38ClN8O3P |
| Mol.Wt. | 613.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014452 |
| CAS No | NA |
| Mol.F. | C29H37ClN9O4P |
| Mol.Wt. | 642.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014453 |
| CAS No | NA |
| Mol.F. | C29H38ClN8O3P |
| Mol.Wt. | 613.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014454 |
| CAS No | NA |
| Mol.F. | C11H9BrN6O |
| Mol.Wt. | 321.1 |
| INV STATUS | In Stock |
| CAT No | SRC-N014455 |
| CAS No | NA |
| Mol.F. | C4H4N4O3 |
| Mol.Wt. | 156.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014456 |
| CAS No | NA |
| Mol.F. | C4H4N4O3 |
| Mol.Wt. | 156.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014457 |
| CAS No | NA |
| Mol.F. | C3H2N4O3 |
| Mol.Wt. | 142.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014458 |
| CAS No | NA |
| Mol.F. | C3H2N4O3 |
| Mol.Wt. | 142.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014459 |
| CAS No | NA |
| Mol.F. | C4H5N3O |
| Mol.Wt. | 111.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014460 |
| CAS No | NA |
| Mol.F. | C6H7N3O3S |
| Mol.Wt. | 201.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014461 |
| CAS No | NA |
| Mol.F. | C19H18FN3O2 |
| Mol.Wt. | 339.4 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014462 |
| CAS No | NA |
| Mol.F. | C12H12N4O5S2 |
| Mol.Wt. | 356.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014463 |
| CAS No | NA |
| Mol.F. | C14H17N7O2 |
| Mol.Wt. | 315.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014464 |
| CAS No | 28698-93-3 |
| Mol.F. | C22H24N4O8 |
| Mol.Wt. | 472.45 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014465 |
| CAS No | NA |
| Mol.F. | C13H14N2O4 |
| Mol.Wt. | 262.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014466 |
| CAS No | NA |
| Mol.F. | C11H9BrN6O |
| Mol.Wt. | 321.13 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |